BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, Georgia Sfakiotaki, Nikolaos Androulakis, Kostas Kalbakis, Charalambos Christophylakis, Antonia Kalykaki, Lambros Vamvakas, Athanasios Kotsakis, Sofia Agelaki, Eleni Diamandidou, Nikolaos Touroutoglou, Adam Chatzidakis, Vassilis Georgoulias, Dimitris Mavroudis and John Souglakos*

BMC Cancer 2007, 7:91 doi:10.1186/1471-2407-7-91

Accesses  

  • Last 30 days: 125 accesses
  • Last 365 days: 1180 accesses
  • All time: 6190 accesses

Cited by

BioMed Central: 2 citations

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations